These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18056831)

  • 41. Functional analysis and extinction of different behavior problems exhibited by the same individual.
    Richman DM; Wacker DP; Asmus JM; Casey SD
    J Appl Behav Anal; 1998; 31(3):475-8. PubMed ID: 9757585
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques.
    Fontenot MB; Padgett EE; Dupuy AM; Lynch CR; De Petrillo PB; Higley JD
    Comp Med; 2005 Feb; 55(1):67-74. PubMed ID: 15766212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of functional analysis methodology in the evaluation of medication effects.
    Crosland KA; Zarcone JR; Lindauer SE; Valdovinos MG; Zarcone TJ; Hellings JA; Schroeder SR
    J Autism Dev Disord; 2003 Jun; 33(3):271-9. PubMed ID: 12908830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
    Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
    Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Loxapine treatment in an autistic child with aggressive behavior: therapeutic challenges.
    Reinblatt SP; Abanilla PK; Jummani R; Coffey B
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):639-43. PubMed ID: 17069553
    [No Abstract]   [Full Text] [Related]  

  • 46. A review of behavioral treatments for self-injurious behaviors of persons with autism spectrum disorders.
    Matson JL; Lovullo SV
    Behav Modif; 2008 Jan; 32(1):61-76. PubMed ID: 18096972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adult head-banging and stereotypic movement disorders.
    Mendez MF; Mirea A
    Mov Disord; 1998 Sep; 13(5):825-8. PubMed ID: 9756153
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Factors associated with the Questions About Behavior Function for functional assessment of low and high rate challenging behaviors in adults with intellectual disability.
    Matson JL; Wilkins J
    Behav Modif; 2009 Mar; 33(2):207-19. PubMed ID: 18559543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of buspirone in autistic children.
    Edwards DJ; Chugani DC; Chugani HT; Chehab J; Malian M; Aranda JV
    J Clin Pharmacol; 2006 May; 46(5):508-14. PubMed ID: 16638734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brief report: Aggressive challenging behaviour in adults with intellectual disability following community resettlement.
    Bhaumik S; Watson JM; Devapriam J; Raju LB; Tin NN; Kiani R; Talbott L; Parker R; Moore L; Majumdar SK; Ganghadaran SK; Dixon K; Das Gupta A; Barrett M; Tyrer F
    J Intellect Disabil Res; 2009 Mar; 53(3):298-302. PubMed ID: 19250390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autism: the treatment of aggressive behaviors.
    Ratey JJ; Mikkelsen E; Sorgi P; Zuckerman HS; Polakoff S; Bemporad J; Bick P; Kadish W
    J Clin Psychopharmacol; 1987 Feb; 7(1):35-41. PubMed ID: 2880874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Self-restraint and self-injury: occurrence and motivational significance.
    Powell SB; Bodfish JW; Parker D; Crawford TW; Lewis MH
    Am J Ment Retard; 1996 Jul; 101(1):41-8. PubMed ID: 8827250
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
    Niederhofer H
    Psychiatr Danub; 2007 Sep; 19(3):189-92. PubMed ID: 17914318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Paramenstrual aggression in mentally retarded adult ameliorated by buspirone.
    Colella RF; Ratey JJ; Glaser AI
    Int J Psychiatry Med; 1992; 22(4):351-6. PubMed ID: 1293064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risperidone in children with autism and serious behavioral problems.
    Valiquette G
    N Engl J Med; 2002 Dec; 347(23):1890-1; author reply 1890-1. PubMed ID: 12472071
    [No Abstract]   [Full Text] [Related]  

  • 58. Aggressive behavior in individuals with moderate to borderline intellectual disabilities who live in a residential facility: an evaluation of functional variables.
    Embregts PJ; Didden R; Schreuder N; Huitink C; van Nieuwenhuijzen M
    Res Dev Disabil; 2009; 30(4):682-8. PubMed ID: 18602246
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioral assessment and treatment of self-injurious behavior in autism.
    Minshawi NF
    Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):875-86, x. PubMed ID: 18775375
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aggressive challenging behaviour and intellectual disability.
    Benson BA; Brooks WT
    Curr Opin Psychiatry; 2008 Sep; 21(5):454-8. PubMed ID: 18650686
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.